Deregulated expression of cytoskeleton related genes in the spinal cord and sciatic nerve of presymptomatic SOD1G93A Amyotrophic Lateral Sclerosis mouse model

Frontiers in Cellular Neuroscience

Volumn 8, Issue MAY, 2014, Pages

  Maximino, Jessica R ^a   de Oliveira, Gabriela ^a   Alves, Chrystian J ^a   Chadi, Gerson ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

ALS; Kif1b microarray; Pre symptomatic; Sciatic nerve; Spinal cord

Indexed keywords

ALPHA ACTININ 3; CYTOSKELETON PROTEIN; DYNACTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; TAU PROTEIN; TREMPAMOTIDE;

ACTIN FILAMENT; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL SELECTION; CELL VIABILITY ASSAY; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; ELECTROPHORESIS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; LASER MICRODISSECTION; MALE; MICROARRAY ANALYSIS; MOTONEURON; MOUSE; NERVE CELL NECROSIS; NERVE FIBER TRANSPORT; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; RNA ISOLATION; SCIATIC NERVE; SPINAL CORD;

EID: 84901590710     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00148     Document Type: Article

References (115)

1. Almer, G., Vukosavic, S., Romero, N., and Przedborski, S. (1999). Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 72, 2415-2425. doi: 10.1046/j.1471-4159.1999.0722415.x
2. Alves, C. J., De Santana, L. P., Dos Santos, A. J., De Oliveira, G. P., Duobles, T., Scorisa, J. M., et al. (2011). Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome. Brain Res. 1394, 90-104. doi: 10.1016/j.brainres.2011.02.060
3. Aronov, S., Aranda, G., Behar, L., and Ginzburg, I. (2002). Visualization of translated tau protein in the axons of neuronal P19 cells and characterization of tau RNP granules. J. Cell Sci. 115, 3817-3827. doi: 10.1242/jcs.00058
4. Baciu, C., Thompson, K. J., Mougeot, J. L., Brooks, B. R., and Weller, J. W. (2012). The LO-BaFL method and ALS microarray expression analysis. BMC Bioinformatics 13, 244. doi: 10.1186/1471-2105-13-244
5. Baraban, M., Anselme, I., Schneider-Maunoury, S., and Giudicelli, F. (2013). Zebrafish embryonic neurons transport messenger RNA to axons and growth cones in vivo. J. Neurosci. 33, 15726-15734. doi: 10.1523/JNEUROSCI.1510-13.2013
6. Bernardini, C., Censi, F., Lattanzi, W., Barba, M., Calcagnini, G., Giuliani, A., et al. (2013). Mitochondrial network genes in the skeletal muscle of amyotrophic lateral sclerosis patients. PLoS ONE 8:e57739. doi: 10.1371/journal.pone.0057739
7. Boillee, S., Vande Velde, C., and Cleveland, D. W. (2006a). ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52, 39-59. doi: 10.1016/j.neuron.2006.09.018
8. Boillee, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., et al. (2006b). Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389-1392. doi: 10.1126/science.1123511
9. Bolis, A., Coviello, S., Visigalli, I., Taveggia, C., Bachi, A., Chishti, A. H., et al. (2009). Dlg1, Sec8, and Mtmr2 regulate membrane homeostasis in Schwann cell myelination. J. Neurosci. 29, 8858-8870. doi: 10.1523/JNEUROSCI.1423-09.2009
10. Boutahar, N., Wierinckx, A., Camdessanche, J. P., Antoine, J. C., Reynaud, E., Lassabliere, F., et al. (2011). Differential effect of oxidative or excitotoxic stress on the transcriptional profile of amyotrophic lateral sclerosis-linked mutant SOD1 cultured neurons. J. Neurosci. Res. 89, 1439-1450. doi: 10.1002/jnr.22672
11. Brockes, J. P., Fields, K. L., and Raff, M. C. (1979). Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res. 165, 105-118.
12. Bryson, J. B., Hobbs, C., Parsons, M. J., Bosch, K. D., Pandraud, A., Walsh, F. S., et al. (2012). Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Hum. Mol. Genet. 21, 3871-3882. doi: 10.1093/hmg/dds215
13. Chen, K., Northington, F. J., and Martin, L. J. (2010). Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice. Brain Struct. Funct. 214, 219-234. doi: 10.1007/s00429-009-0226-4
14. Conforti, L., Dell'agnello, C., Calvaresi, N., Tortarolo, M., Giorgini, A., Coleman, M. P., et al. (2003). Kif1Bbeta isoform is enriched in motor neurons but does not change in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. Res. 71, 732-739. doi: 10.1002/jnr.10517
15. Cooper-Knock, J., Kirby, J., Ferraiuolo, L., Heath, P. R., Rattray, M., and Shaw, P. J. (2012). Gene expression profiling in human neurodegenerative disease. Nat. Rev. Neurol. 8, 518-530. doi: 10.1038/nrneurol.2012.156
16. Cox, L. E., Ferraiuolo, L., Goodall, E. F., Heath, P. R., Higginbottom, A., Mortiboys, H., et al. (2010). Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS ONE 5:e9872. doi: 10.1371/journal.pone.0009872
17. Cox, P. R., and Zoghbi, H. Y. (2000). Sequencing, expression analysis, and mapping of three unique human tropomodulin genes and their mouse orthologs. Genomics 63, 97-107. doi: 10.1006/geno.1999.6061
18. Dadon-Nachum, M., Melamed, E., and Offen, D. (2011). The "dying-back" phenomenon of motor neurons in ALS. J. Mol. Neurosci. 43, 470-477. doi: 10.1007/s12031-010-9467-1
19. Dangond, F., Hwang, D., Camelo, S., Pasinelli, P., Frosch, M. P., Stephanopoulos, G., et al. (2004). Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol. Genomics 16, 229-239. doi: 10.1152/physiolgenomics.00087.2001
20. Deng, H. X., Zhai, H., Fu, R., Shi, Y., Gorrie, G. H., Yang, Y., et al. (2007). Distal axonopathy in an alsin-deficient mouse model. Hum. Mol. Genet. 16, 2911-2920. doi: 10.1093/hmg/ddm251
21. De Oliveira, G. P., Alves, C. J., and Chadi, G. (2013). Early gene expression changes in spinal cord from SOD1(G93A) Amyotrophic Lateral Sclerosis animal model. Front. Cell Neurosci. 7:216. doi: 10.3389/fncel.2013.00216
22. De Oliveira, G. P., Maximino, J. R., Lin, C. J., and Chadi, G. (2009). A method to immunolabel rodent spinal cord neurons and glia for molecular study in specific laser microdissected cells involved in neurodegenerative disorders. J. Mol. Histol. 40, 217-225. doi: 10.1007/s10735-009-9233-2
23. De Oliveira, G. P., Maximino, J. R., Maschietto, M., Zanoteli, E., Puga, R. D., Lima, L., et al. (2014). Early gene expression changes in skeletal muscle from SOD1(G93A) amyotrophic lateral sclerosis animal model. Cell. Mol. Neurobiol. 34, 451-462. doi: 10.1007/s10571-014-0029-x
24. De Winter, F., Vo, T., Stam, F. J., Wisman, L. A., Bar, P. R., Niclou, S. P., et al. (2006). The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol. Cell. Neurosci. 32, 102-117. doi: 10.1016/j.mcn.2006.03.002
25. Dibaj, P., Steffens, H., Zschuntzsch, J., Nadrigny, F., Schomburg, E. D., Kirchhoff, F., et al. (2011). In Vivo imaging reveals distinct inflammatory activity of CNS microglia versus PNS macrophages in a mouse model for ALS. PLoS ONE 6:e17910. doi: 10.1371/journal.pone.0017910
26. Dong, Z., Sinanan, A., Parkinson, D., Parmantier, E., Mirsky, R., and Jessen, K. R. (1999). Schwann cell development in embryonic mouse nerves. J. Neurosci. Res. 56, 334-348. doi: 10.1002/(SICI)1097-4547(19990515)56:4<334::AID-JNR2>3.0.CO;2-#
27. Dupuis, L., De Tapia, M., Rene, F., Lutz-Bucher, B., Gordon, J. W., Mercken, L., et al. (2000). Differential screening of mutated SOD1 transgenic mice reveals early up-regulation of a fast axonal transport component in spinal cord motor neurons. Neurobiol. Dis. 7, 274-285. doi: 10.1006/nbdi.2000.0292
28. Ferraiuolo, L., De Bono, J. P., Heath, P. R., Holden, H., Kasher, P., Channon, K. M., et al. (2009). Transcriptional response of the neuromuscular system to exercise training and potential implications for ALS. J. Neurochem. 109, 1714-1724. doi: 10.1111/j.1471-4159.2009.06080.x
29. Ferraiuolo, L., Heath, P. R., Holden, H., Kasher, P., Kirby, J., and Shaw, P. J. (2007). Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J. Neurosci. 27, 9201-9219. doi: 10.1523/JNEUROSCI.1470-07.2007
30. Ferraiuolo, L., Kirby, J., Grierson, A. J., Sendtner, M., and Shaw, P. J. (2011). Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 7, 616-630. doi: 10.1038/nrneurol.2011.152
31. Fischer, L. R., Culver, D. G., Tennant, P., Davis, A. A., Wang, M., Castellano-Sanchez, A., et al. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185, 232-240. doi: 10.1016/j.expneurol.2003.10.004
32. Fukada, Y., Yasui, K., Kitayama, M., Doi, K., Nakano, T., Watanabe, Y., et al. (2007). Gene expression analysis of the murine model of amyotrophic lateral sclerosis: studies of the Leu126delTT mutation in SOD1. Brain Res. 1160, 1-10. doi: 10.1016/j.brainres.2007.05.044
33. Gama Sosa, M. A., De Gasperi, R., and Elder, G. A. (2012). Modeling human neurodegenerative diseases in transgenic systems. Hum. Genet. 131, 535-563. doi: 10.1007/s00439-011-1119-1
34. Gentil, B. J., and Cooper, L. (2012). Molecular basis of axonal dysfunction and traffic impairments in CMT. Brain Res. Bull. 88, 444-453. doi: 10.1016/j.brainresbull.2012.05.003
35. Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., et al. (2004). Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80. doi: 10.1186/gb-2004-5-10-r80
36. Goldman, N., Chandler-Militello, D., Langevin, H. M., Nedergaard, M., and Takano, T. (2013). Purine receptor mediated actin cytoskeleton remodeling of human fibroblasts. Cell Calcium 53, 297-301. doi: 10.1016/j.ceca.2013.01.004
37. Gould, L., and Kendall, N. R. (2011). Role of the rumen in copper and thiomolybdate absorption. Nutr. Res. Rev. 24, 176-182. doi: 10.1017/S0954422411000059
38. Gould, T. W., and Oppenheim, R. W. (2011). Motor neuron trophic factors: therapeutic use in ALS? Brain Res. Rev. 67, 1-39. doi: 10.1016/j.brainresrev.2010.10.003
39. Guipponi, M., Li, Q. X., Hyde, L., Beissbarth, T., Smyth, G. K., Masters, C. L., et al. (2010). SAGE analysis of genes differentially expressed in presymptomatic TgSOD1G93A transgenic mice identified cellular processes involved in early stage of ALS pathology. J. Mol. Neurosci. 41, 172-182. doi: 10.1007/s12031-009-9317-1
40. Gundlach, A. L., Grabara, C. S., Johnston, G. A., and Harper, P. A. (1990). Receptor alterations associated with spinal motoneuron degeneration in bovine Akabane disease. Ann. Neurol. 27, 513-519. doi: 10.1002/ana.410270510
41. Gurney, M. E. (1994). Transgenic-mouse model of amyotrophic lateral sclerosis. N. Engl. J. Med. 331, 1721-1722. doi: 10.1056/NEJM199412223312516
42. Hadano, S., Hand, C. K., Osuga, H., Yanagisawa, Y., Otomo, A., Devon, R. S., et al. (2001). A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet. 29, 166-173. doi: 10.1038/ng1001-166
43. Hadano, S., Otomo, A., Kunita, R., Suzuki-Utsunomiya, K., Akatsuka, A., Koike, M., et al. (2010). Loss of ALS2/Alsin exacerbates motor dysfunction in a SOD1-expressing mouse ALS model by disturbing endolysosomal trafficking. PLoS ONE 5:e9805. doi: 10.1371/journal.pone.0009805
44. Hafezparast, M., Klocke, R., Ruhrberg, C., Marquardt, A., Ahmad-Annuar, A., Bowen, S., et al. (2003). Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300, 808-812. doi: 10.1126/science.1083129
45. Hanyu, N., Oguchi, K., Yanagisawa, N., and Tsukagoshi, H. (1982). Degeneration and regeneration of ventral root motor fibers in amyotrophic lateral sclerosis. Morphometric studies of cervical ventral roots. J. Neurol. Sci. 55, 99-115. doi: 10.1016/0022-510X(82)90173-3
46. Heads, T., Pollock, M., Robertson, A., Sutherland, W. H., and Allpress, S. (1991). Sensory nerve pathology in amyotrophic lateral sclerosis. Acta Neuropathol. 82, 316-320.
47. Hensley, K., Floyd, R. A., Gordon, B., Mou, S., Pye, Q. N., Stewart, C., et al. (2002). Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J. Neurochem. 82, 365-374. doi: 10.1046/j.1471-4159.2002.00968.x
48. Herzenberg, L. A., Tung, J., Moore, W. A., and Parks, D. R. (2006). Interpreting flow cytometry data: a guide for the perplexed. Nat. Immunol. 7, 681-685. doi: 10.1038/ni0706-681
49. Huang Da, W., Sherman, B. T., Stephens, R., Baseler, M. W., Lane, H. C., and Lempicki, R. A. (2008). DAVID gene ID conversion tool. Bioinformation 2, 428-430. doi: 10.6026/97320630002428
50. Hulsen, T., De Vlieg, J., and Alkema, W. (2008). BioVenn-a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics 9:488. doi: 10.1186/1471-2164-9-488
51. Husseman, J. W., Nochlin, D., and Vincent, I. (2000). Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases. Neurobiol. Aging 21, 815-828. doi: 10.1016/S0197-4580(00)00221-9
52. Ito, M., Swanson, B., Sussman, M. A., Kedes, L., and Lyons, G. (1995). Cloning of tropomodulin cDNA and localization of gene transcripts during mouse embryogenesis. Dev. Biol. 167, 317-328. doi: 10.1006/dbio.1995.1026
53. Jablonka, S., Wiese, S., and Sendtner, M. (2004). Axonal defects in mouse models of motoneuron disease. J. Neurobiol. 58, 272-286. doi: 10.1002/neu.10313
54. Jiang, Y. M., Yamamoto, M., Kobayashi, Y., Yoshihara, T., Liang, Y., Terao, S., et al. (2005). Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann. Neurol. 57, 236-251. doi: 10.1002/ana.20379
55. Jiang, Y. M., Yamamoto, M., Tanaka, F., Ishigaki, S., Katsuno, M., Adachi, H., et al. (2007). Gene expressions specifically detected in motor neurons (dynactin 1, early growth response 3, acetyl-CoA transporter, death receptor 5, and cyclin C) differentially correlate to pathologic markers in sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 66, 617-627. doi: 10.1097/nen.0b013e318093ece3
56. Keller, A. F., Gravel, M., and Kriz, J. (2009). Live imaging of amyotrophic lateral sclerosis pathogenesis: disease onset is characterized by marked induction of GFAP in Schwann cells. Glia 57, 1130-1142. doi: 10.1002/glia.20836
57. Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., et al. (2011). Amyotrophic lateral sclerosis. Lancet 377, 942-955. doi: 10.1016/S0140-6736(10)
58. Kiryu-Seo, S., and Kiyama, H. (2011). The nuclear events guiding successful nerve regeneration. Front. Mol. Neurosci. 4:53. doi: 10.3389/fnmol.2011.00053
59. Koh, S. H., Roh, H., Lee, S. M., Kim, H. J., Kim, M., Lee, K. W., et al. (2005). Phosphatidylinositol 3-kinase activator reduces motor neuronal cell death induced by G93A or A4V mutant SOD1 gene. Toxicology 213, 45-55. doi: 10.1016/j.tox.2005.05.009
60. Korner, S., Boselt, S., Thau, N., Rath, K. J., Dengler, R., and Petri, S. (2013). Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: neuroprotective or neurotoxic properties of sirtuins in ALS? Neurodegener. Dis. 11, 141-152. doi: 10.1159/000338048
61. Kudo, L. C., Parfenova, L., Vi, N., Lau, K., Pomakian, J., Valdmanis, P., et al. (2010). Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis. Hum. Mol. Genet. 19, 3233-3253. doi: 10.1093/hmg/ddq232
62. Kuzma-Kozakiewicz, M., Chudy, A., Gajewska, B., Dziewulska, D., Usarek, E., and Baranczyk-Kuzma, A. (2013). Kinesin expression in the central nervous system of humans and transgenic hSOD1G93A mice with amyotrophic lateral sclerosis. Neurodegener. Dis. 12, 71-80. doi: 10.1159/000339529
63. Lai, C., Xie, C., Shim, H., Chandran, J., Howell, B. W., and Cai, H. (2009). Regulation of endosomal motility and degradation by amyotrophic lateral sclerosis 2/alsin. Mol. Brain 2, 23. doi: 10.1186/1756-6606-2-23
64. Levine, J. B., Kong, J., Nadler, M., and Xu, Z. (1999). Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS). Glia 28, 215-224. doi: 10.1002/(SICI)1098-1136(199912)28:3<215::AID-GLIA5>3.0.CO;2-C
65. Liu, J. X., Brannstrom, T., Andersen, P. M., and Pedrosa-Domellof, F. (2013). Distinct changes in synaptic protein composition at neuromuscular junctions of extraocular muscles versus limb muscles of ALS donors. PLoS ONE8:e57473. doi: 10.1371/journal.pone.0057473
66. Lobsiger, C. S., Boillee, S., and Cleveland, D. W. (2007). Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons. Proc. Natl. Acad. Sci. U.S.A. 104, 7319-7326. doi: 10.1073/pnas.0702230104
67. Lyons, D. A., Naylor, S. G., Scholze, A., and Talbot, W. S. (2009). Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons. Nat. Genet. 41, 854-858. doi: 10.1038/ng.376
68. Magrane, J., and Manfredi, G. (2009). Mitochondrial function, morphology, and axonal transport in amyotrophic lateral sclerosis. Antioxid. Redox Signal. 11, 1615-1626. doi: 10.1089/ARS.2009.2604
69. Malaspina, A., Ngoh, S. F., Ward, R. E., Hall, J. C., Tai, F. W., Yip, P. K., et al. (2010). Activation transcription factor-3 activation and the development of spinal cord degeneration in a rat model of amyotrophic lateral sclerosis. Neuroscience 169, 812-827. doi: 10.1016/j.neuroscience.2010.04.053
70. Malmqvist, T., Anthony, K., and Gallo, J. M. (2014). Tau mRNA is present in axonal RNA granules and is associated with elongation factor 1A. Brain Res. doi: 10.1016/j.brainres.2013.12.033. [Epub ahead of print].
71. McGeer, P. L., and McGeer, E. G. (2002). Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve26, 459-470. doi: 10.1002/mus.10191
72. Monk, K. R., and Talbot, W. S. (2009). Genetic dissection of myelinated axons in zebrafish. Curr. Opin. Neurobiol. 19, 486-490. doi: 10.1016/j.conb.2009.08.006
73. Morfini, G. A., Bosco, D. A., Brown, H., Gatto, R., Kaminska, A., Song, Y., et al. (2013). Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase. PLoS ONE 8:e65235. doi: 10.1371/journal.pone.0065235
74. Nangaku, M., Sato-Yoshitake, R., Okada, Y., Noda, Y., Takemura, R., Yamazaki, H., et al. (1994). KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell 79, 1209-1220. doi: 10.1016/0092-8674(94)90012-4
75. Niapour, A., Karamali, F., Karbalaie, K., Kiani, A., Mardani, M., Nasr-Esfahani, M. H., et al. (2010). Novel method to obtain highly enriched cultures of adult rat Schwann cells. Biotechnol. Lett. 32, 781-786. doi: 10.1007/s10529-010-0230-z
76. Niewiadomska, G., Mietelska-Porowska, A., and Mazurkiewicz, M. (2011). The cholinergic system, nerve growth factor and the cytoskeleton. Behav. Brain Res. 221, 515-526. doi: 10.1016/j.bbr.2010.02.024
77. Nishimura, A. L., Mitne-Neto, M., Silva, H. C., Richieri-Costa, A., Middleton, S., Cascio, D., et al. (2004). A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 75, 822-831. doi: 10.1086/425287
78. Nishimura, Y., Hayashi, M., Inada, H., and Tanaka, T. (1999). Molecular cloning and characterization of mammalian homologues of vesicle-associated membrane protein-associated (VAMP-associated) proteins. Biochem. Biophys. Res. Commun. 254, 21-26. doi: 10.1006/bbrc.1998.9876
79. Offen, D., Barhum, Y., Melamed, E., Embacher, N., Schindler, C., and Ransmayr, G. (2009). Spinal cord mRNA profile in patients with ALS: comparison with transgenic mice expressing the human SOD-1 mutant. J. Mol. Neurosci. 38, 85-93. doi: 10.1007/s12031-007-9004-z
80. Okada, Y., Yamazaki, H., Sekine-Aizawa, Y., and Hirokawa, N. (1995). The neuron-specific kinesin superfamily protein KIF1A is a unique monomeric motor for anterograde axonal transport of synaptic vesicle precursors. Cell81, 769-780. doi: 10.1016/0092-8674(95)90538-3
81. Olsen, M. K., Roberds, S. L., Ellerbrock, B. R., Fleck, T. J., McKinley, D. K., and Gurney, M. E. (2001). Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann. Neurol. 50, 730-740. doi: 10.1002/ana.1252
82. Oudega, M., Xu, X. M., Guenard, V., Kleitman, N., and Bunge, M. B. (1997). A combination of insulin-like growth factor-I and platelet-derived growth factor enhances myelination but diminishes axonal regeneration into Schwann cell grafts in the adult rat spinal cord. Glia 19, 247-258. doi: 10.1002/(SICI)1098-1136(199703)19:3<247::AID-GLIA7>3.0.CO;2-W
83. Pantelidou, M., Zographos, S. E., Lederer, C. W., Kyriakides, T., Pfaffl, M. W., and Santama, N. (2007). Differential expression of molecular motors in the motor cortex of sporadic ALS. Neurobiol. Dis. 26, 577-589. doi: 10.1016/j.nbd.2007.02.005
84. Parkhouse, W. S., Cunningham, L., McFee, I., Miller, J. M., Whitney, D., Pelech, S. L., et al. (2008). Neuromuscular dysfunction in the mutant superoxide dismutase mouse model of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 9, 24-34. doi: 10.1080/17482960701725646
85. Pasinelli, P., and Brown, R. H. (2006). Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7, 710-723. doi: 10.1038/nrn1971
86. Perrie, W. T., Lee, G. T., Curtis, E. M., Sparke, J., Buller, J. R., and Rossi, M. L. (1993). Changes in the myelinated axons of femoral nerve in amyotrophic lateral sclerosis. J. Neural Transm. Suppl. 39, 223-233. doi: 10.1155/2011/718987
87. Perrin, F. E., Boisset, G., Docquier, M., Schaad, O., Descombes, P., and Kato, A. C. (2005). No widespread induction of cell death genes occurs in pure motoneurons in an amyotrophic lateral sclerosis mouse model. Hum. Mol. Genet. 14, 3309-3320. doi: 10.1093/hmg/ddi357
88. Pradat, P. F., Dubourg, O., De Tapia, M., Di Scala, F., Dupuis, L., Lenglet, T., et al. (2012). Muscle gene expression is a marker of amyotrophic lateral sclerosis severity. Neurodegener. Dis. 9, 38-52. doi: 10.1159/000329723
89. Rothstein, J. D. (2009). Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann. Neurol. 65(Suppl. 1), S3-S9. doi: 10.1002/ana.21543
90. Schwab, J. M., Frei, E., Klusman, I., Schnell, L., Schwab, M. E., and Schluesener, H. J. (2001). AIF-1 expression defines a proliferating and alert microglial/macrophage phenotype following spinal cord injury in rats. J. Neuroimmunol. 119, 214-222. doi: 10.1016/S0165-5728(01)00375-7
91. Scorisa, J. M., Duobles, T., Oliveira, G. P., Maximino, J. R., and Chadi, G. (2010). The review of the methods to obtain non-neuronal cells to study glial influence on Amyotrophic Lateral Sclerosis pathophysiology at molecular level in vitro. Acta Cir. Bras. 25, 281-289. doi: 10.1590/S0102-86502010000300011
92. Shapiro, H. M. (2005). Practical Flow Cytometry. New York, NY: Wiley-Liss.
93. Shaw, C. E., Al-Chalabi, A., and Leigh, N. (2001). Progress in the pathogenesis of amyotrophic lateral sclerosis. Curr. Neurol. Neurosci. Rep. 1, 69-76. doi: 10.1007/s11910-001-0078-7
94. Smyth, G. K. (2005). "Limma: linear models for microarray data, " in Bioinformatics and Computational Biology Solutions using R and Bioconductor, eds V. C. R. Gentleman, S. Dudoit, R. Irizarry, and W. Huber (New York, NY: Springer), 397-420.
95. Spadoni, O., Crestini, A., Piscopo, P., Malvezzi-Campeggi, L., Carunchio, I., Pieri, M., et al. (2009). Gene expression profiles of APP and BACE1 in Tg SOD1G93A cortical cells. Cell. Mol. Neurobiol. 29, 635-641. doi: 10.1007/s10571-009-9356-8
96. Strey, C. W., Spellman, D., Stieber, A., Gonatas, J. O., Wang, X., Lambris, J. D., et al. (2004). Dysregulation of stathmin, a microtubule-destabilizing protein, and up-regulation of Hsp25, Hsp27, and the antioxidant peroxiredoxin 6 in a mouse model of familial amyotrophic lateral sclerosis. Am. J. Pathol. 165, 1701-1718. doi: 10.1016/S0002-9440(10)63426-8
97. Strom, A. L., Shi, P., Zhang, F., Gal, J., Kilty, R., Hayward, L. J., et al. (2008). Interaction of amyotrophic lateral sclerosis (ALS)-related mutant copper-zinc superoxide dismutase with the dynein-dynactin complex contributes to inclusion formation. J. Biol. Chem. 283, 22795-22805. doi: 10.1074/jbc.M800276200
98. Sunico, C. R., Dominguez, G., Garcia-Verdugo, J. M., Osta, R., Montero, F., and Moreno-Lopez, B. (2011). Reduction in the motoneuron inhibitory/excitatory synaptic ratio in an early-symptomatic mouse model of amyotrophic lateral sclerosis. Brain Pathol. 21, 1-15. doi: 10.1111/j.1750-3639.2010.00417.x
99. Taes, I., Timmers, M., Hersmus, N., Bento-Abreu, A., Van Den Bosch, L., Van Damme, P., et al. (2013). Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS. Hum. Mol. Genet. 22, 1783-1790. doi: 10.1093/hmg/ddt028
100. Tanaka, F., Ikenaka, K., Yamamoto, M., and Sobue, G. (2012). Neuropathology and omics in motor neuron diseases. Neuropathology 32, 458-462. doi: 10.1111/j.1440-1789.2011.01281.x
101. Tanaka, F., Niwa, J., Ishigaki, S., Katsuno, M., Waza, M., Yamamoto, M., et al. (2006). Gene expression profiling toward understanding of ALS pathogenesis. Ann. N.Y. Acad. Sci. 1086, 1-10. doi: 10.1196/annals.1377.011
102. Ticozzi, N., Ratti, A., and Silani, V. (2010). Protein aggregation and defective RNA metabolism as mechanisms for motor neuron damage. CNS Neurol. Disord. Drug Targets 9, 285-296. doi: 10.2174/187152710791292585
103. Tripathi, V. B., and Al-Chalabi, A. (2008). Molecular insights and therapeutic targets in amyotrophic lateral sclerosis. CNS Neurol. Disord. Drug Targets 7, 11-19. doi: 10.2174/187152708783885110
104. Usuki, S., Kamitani, T., Matsuo, Y., and Yu, R. K. (2012). Pathobiochemical effect of acylated steryl-beta-glucoside on aggregation and cytotoxicity of alpha-synuclein. Neurochem. Res. 37, 1261-1266. doi: 10.1007/s11064-011-0662-4
105. Van Gelder, R. N., Von Zastrow, M. E., Yool, A., Dement, W. C., Barchas, J. D., and Eberwine, J. H. (1990). Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc. Natl. Acad. Sci. U.S.A. 87, 1663-1667.
106. Vargas, M. R., Pehar, M., Diaz-Amarilla, P. J., Beckman, J. S., and Barbeito, L. (2008). Transcriptional profile of primary astrocytes expressing ALS-linked mutant SOD1. J Neurosci. Res. 86, 3515-3525. doi: 10.1002/jnr.21797
107. Vinsant, S., Mansfield, C., Jimenez-Moreno, R., Del Gaizo Moore, V., Yoshikawa, M., Hampton, T. G., et al. (2013). Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part II, results and discussion. Brain Behav. 3, 431-457. doi: 10.1002/brb3.142
108. Wang, Y., Kaiser, C. E., Frett, B., and Li, H. Y. (2013). Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators. J. Med. Chem. 56, 5219-5230. doi: 10.1021/jm3017706
109. Warita, H., Itoyama, Y., and Abe, K. (1999). Selective impairment of fast anterograde axonal transport in the peripheral nerves of asymptomatic transgenic mice with a G93A mutant SOD1 gene. Brain Res. 819, 120-131. doi: 10.1016/S0006-8993(98)01351-1
110. White, F. V., Ceccarini, C., Georgieff, I., Matthieu, J. M., and Costantino-Ceccarini, E. (1983). Growth properties and biochemical characterization of mouse Schwann cells cultured in vitro. Exp. Cell. Res. 148, 183-194. doi: 10.1016/0014-4827(83)90198-2
111. Williamson, T. L., and Cleveland, D. W. (1999). Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 2, 50-56. doi: 10.1038/4553
112. Xiao, S., McLean, J., and Robertson, J. (2006). Neuronal intermediate filaments and ALS: a new look at an old question. Biochim. Biophys. Acta 1762, 1001-1012. doi: 10.1016/j.bbadis.2006.09.003
113. Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., et al. (2008). Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11, 251-253. doi: 10.1038/nn2047
114. Yang, Y., Hentati, A., Deng, H. X., Dabbagh, O., Sasaki, T., Hirano, M., et al. (2001). The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet. 29, 160-165. doi: 10.1038/ng1001-160
115. Yoshihara, T., Ishigaki, S., Yamamoto, M., Liang, Y., Niwa, J., Takeuchi, H., et al. (2002). Differential expression of inflammation-and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 80, 158-167. doi: 10.1046/j.0022-3042.2001.00683.x